THROMBOPROPHYLAXIS IN SURGICAL PATIENTS
Accepted
28 March 2026
Available Online
15 September 2018
Abstract
SURGICAL PATIENT S HAVE AN INCREASED RISK FOR VENOUS THROMBOEMBOLISM, THE MOST COMMON PREVENTABLE CAUSE OF DEATH IN THIS CATEGORY OF PATIENTS. THROMBOPROPHYLAXIS WITH MECHANICAL METHODS, SUCH AS INTERMITENT PNEUMATIC LEG COMPRESSION AND GRADUATED COMPRESSION STOCKS, AND ANTICOAGULANT AGENTS, SUCH AS UNFRACTIONED HEPARIN AND LOW MOLECULAR WEIGHT HEPARIN ARE COMMONLY USE D TO PREVENT THROMBOSIS,THUS REDUCING MORBIDITY AND MORTALITY IN THESE PATIENTS.
Keywords
VENOUS THROMBOEMBOLISM
ANTICOAGULANTS
THROMBOPROPHYLAXIS
Full Text
The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.
References
[1]
Geerts W, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Chest. 2001;119:132S-175S.
[2]
Stratton MA, Anderson FA, Bussey HI et a l. Prevention of venous thromboembolism:adherence to the 1995 American College of Chest Physicians Consensus Guidelinesfor Surgical Patients. Arch Intern Med.2000;160:334-40.
[3]
O’Donnell M., Weitz IJ. Thromboprophylaxis in surgical patients. Can J Surg. 2003;46:2.
[4]
Bick RL, Kaplan LB. Thromboprophylaxis in surgical patients. Eur J Med Res. 2004.9: 104-111.
[5]
Silverstein MD, Heit JA, Mohr DN et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Int Med. 1998.158: 585.
[6]
McIntyre K. Medicolegal implications of the consensus conference. Chest. 2001.119: 337S.
[7]
Bick RL. Introduction to thrombosis: proficient and cost-effective approaches to thrombosis. Hematol Oncol Clin North Am. 2001 17: m1.
[8]
Bick RL. Management of venous thrombosis and thromboembolism: prevention and treatment. Surg Technol Int. 2002. 10: 226.
[9]
Manea M, Marcu D, Pantea Stoian A, Gaman MA, Gaman AM, Socea B, Neagu TP, Stanescu AM, Bratu O, Diaconu C. Heart failure with preserved ejection fraction and atrial fibrillation. A review. Revista de chimie, 2018, 69(11): 4180-4184.
[10]
Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta -analysis of the randomi sed trials. Lancet 2001;358:9-15.
[11]
Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin:Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-302.
[12]
Diaconu CC, Manea M., Iancu MA , Stanescu AMA, Socea B, Spinu DA, Marcu D, Bratu OG. Hiponatremia in patients with heart failure: a prognostic marker. Revista de Chimie. 2018. 69; 5:1071-1074.
[13]
Diaconu CC, Stănescu AMA, Pantea Stoian A, Tincu RC, Cobilinschi C, Dragomirescu RIF, Socea B , Spînu DA, Marcu D, Socea LI, Bratu OG. Hyperkalemia and cardiovascular diseases: new molecules for the treatment. Rev Chim (Bucharest) 2018, 69(6):1367-1370.
[14]
Diaconu CC, Dragoi CM, Bratu OG, Neagu TP, Pantea Stoian A, Cobelschi PC, Nicolae AC, Iancu MA, Hainarosie R, Stanescu AMA, Socea B. New approaches and perspectives for the pharmacological treatment of arterial hypertension. Farmacia 2018, 66(3):408-415.
[15]
Turpie AG. Pentasaccharide. A clinical trials update: lessons for practice. Am Heart J 2001;142:S9-15.
[16]
Amarigiri SV, Lees TA. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 2000;(3):CD001484.
[17]
Agnelli G, Piovella F, Buoncristiani P et al. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of VTE af ter elective neurosurgery . N Engl J Med 1998;339:80-5.
[18]
Constantinoiu S, Bârlă R, Iosif C, Cociu L, Gîndea C, Hoară P, Bratu O, Ruşitoru L. Difficulties in diagnosis and surgical treatment of a giant retroperitoneal lipoma. Chirurgia 2009;104(3): 363-367.
[19]
Socea B, Nica A, Bratu O, Diaconu C, Smaranda A, Socea L, Bertesteanu S, Dimitriu M, Carap A, Constantin V. Incidental finding of a sigmoid intussusception associated with rectal prolapse-a case report. Archives of the Balkan Medical Union, 2018, 53(1), p. 143-146.
[20]
Socea B, Nica A, Smaranda C, Carâp A, Socea L, Dimitriu M, Bratu O, Moculescu C, Berteșt eanu Ș, Constantin V. Solitary cecum diverticulitis – A surprising diagnosis. Archives of the Balkan Medical Union, 2017, 52(4), p. 467-470.
[21]
White RH, Zhou H, Kim J, Romano PS. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Int Med. 2000. 160: 2033.
[22]
Diaconescu D, Stoian Pantea A, Socea L, Stanescu AM, Iancu M, Socea B, Pituru S, Bratu O, Diaconu C. Hepatorenal Syndrome: A Review. Archives of the Balkan Medical Union, 2018, 53(2), pag. 239-245.
[23]
Draghici T, Negreanu L, Bratu O, Tincu R, Socea B, Iancu M, Stanescu AM, Diaconu C . Liver abnormalities in patients with heart failure. Archives of the Balkan Medical Union, 2018, 53, (1), p. 76-81.
[24]
Niculae A, Peride I, Vinereanu V, Rădulescu D, Bratu O, Geavlete B, Checheriță IA. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal sign ificance (MGRS). Rom J Morphol Embriol 2017;58(3): 1065-1068.
[25]
Hull RD, Pineo GF, Francis C et. al. Low molecular- weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients. Arch Int Med. 2000. 160: 2199.
[26]
Paraschiv B, Dediu G, Iancu A, Bratu O, Diaconu C. Superior vena cava syndrome. Archives of the Balkan Medical Union, 2017, 52(1), p. 39-43.
[27]
Mititelu R, Bratu O. Radionuclide Imaging. An Update on the Use of Dynamic Renal Scintigraphy. Modern Medicine, 2017, 24(4), p. 199-203.
[28]
Bick Rl. Recurrent miscarriage syndrome and infertility caused by blood coagulation or Platelet defects. Hematol Oncol Clin North Am. 2000. 14: 1117.
[29]
Caprini J, Arcelus J, Sehgal LR et al. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery: A survey of practice in the United States. Int Angiol. 2002. 21: 78.
[30]
Safta, Andreea N., Constantin, Vlad D., Socea, Laura I., Socea, Bogdan. The efficiency of low molecular weight heparins in the prophylaxis of ven ous thromboembolic complications in general surgery. Farmacia, 2012, 60(1): 127-137.
[31]
Veronica Calborean, Victor Gheorman, Vlad -Dumitru Baleanu et al. Arrythmia risk in pacients with chronic hepatic disease. Revista de Chimie, 69(11): 3337-3340